Literature DB >> 14730040

Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.

Zhen J Wang1, Gautham P Reddy, Michael B Gotway, Charles B Higgins, David M Jablons, Mohan Ramaswamy, Randall A Hawkins, W Richard Webb.   

Abstract

Imaging plays an essential role in the evaluation of malignant pleural mesothelioma (MPM). Computed tomography is the primary imaging modality used for the diagnosis and staging of MPM. Magnetic resonance (MR) imaging and, more recently, positron emission tomography (PET) have emerged as modalities that can provide additional important diagnostic and prognostic information to help further delineate the extent of disease, especially in surgical candidates. Use of MR imaging performed with different pulse sequences and gadolinium-based contrast material can improve the detection of tumor extension, especially to the chest wall and diaphragm. PET can provide both anatomic and metabolic information, especially in cases of extrathoracic and mediastinal nodal metastasis. Each imaging modality has its advantages and limitations, but their combined use is crucial in determining the most appropriate treatment options for patients with MPM. Copyright RSNA, 2004

Entities:  

Mesh:

Year:  2004        PMID: 14730040     DOI: 10.1148/rg.241035058

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  48 in total

1.  Coarse pleural calcification in a mesothelioma patient raises the possibility of a rare tumour subtype: osteoblastic sarcomatoid mesothelioma.

Authors:  A M Mortimer; J Rowlands; P Murphy
Journal:  Br J Radiol       Date:  2011-05       Impact factor: 3.039

2.  Desmoplastic small round cell tumor: A case report of a rare differential diagnosis of solid tumors of the pleura.

Authors:  Yuan Cao; Ying Chen; L I Yang; Zi-Hua Qian; Shu-Gao Han; Qing-Hai Li; Ri-Sheng Yu
Journal:  Oncol Lett       Date:  2015-09-07       Impact factor: 2.967

3.  [Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma].

Authors:  A Scherpereel; P Astoul; P Baas; T Berghmans; H Clayson; P de Vuyst; H Dienemann; F Galateau-Salle; C Hennequin; G Hillerdal; C Le Pe'choux; L Mutti; J-C Pairon; R Stahel; P van Houtte; J van Meerbeeck; D Waller; W Weder
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-10

4.  Peritoneal mesothelioma: an unusual cause of an acute phase response presenting to the rheumatologist.

Authors:  S S Hamdulay; H T Cook; N Strickland; K A Davies; J C Mason
Journal:  Clin Rheumatol       Date:  2006-01-14       Impact factor: 2.980

Review 5.  Volumetric assessment in malignant pleural mesothelioma.

Authors:  David J Murphy; Ritu R Gill
Journal:  Ann Transl Med       Date:  2017-06

Review 6.  Management of malignant pleural mesothelioma-The European experience.

Authors:  Isabelle Opitz
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

Review 7.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

8.  Malignant pleural mesothelioma.

Authors:  Sukhesh Rao
Journal:  Lung India       Date:  2009-04

9.  North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.

Authors:  Ritu R Gill; David P Naidich; Alan Mitchell; Michelle Ginsberg; Jeremy Erasmus; Samuel G Armato; Christopher Straus; Sharyn Katz; Demetrois Patios; William G Richards; Valerie W Rusch
Journal:  J Thorac Oncol       Date:  2016-05-12       Impact factor: 15.609

10.  Tract metastasis from previously unknown malignant pleural mesothelioma: a case report.

Authors:  Tommaso Bartalena; Maria Francesca Rinaldi; Nicola Sverzellati; Vincenzo Allegri; Stefano Fanti
Journal:  Cases J       Date:  2009-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.